Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia

Virology

Volumn 448, Issue , 2014, Pages 314-321

  Kalantari, Mina ^a   Osann, Kathryn ^a   Calleja Macias, Itzel E ^b   Kim, Seong ^b   Yan, Bing ^b   Jordan, Sara ^b   Chase, Dana M ^b   Tewari, Krishnansu S ^b   Bernard, Hans Ulrich ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Cancer progression; DAPK gene; DNA methylation; Epigenetics; Papillomaviruses

Indexed keywords

AMPLICON; ANIMAL CELL; ARTICLE; CANCER GROWTH; DAPK GENE; DISEASE MARKER; DNA METHYLATION; EPIGENETICS; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; L1 GENE; L2 GENE; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VIRUS TYPING;

EID: 84887373787     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.032     Document Type: Article

References (45)

1. Arias-Pulido H., Peyton C.L., Joste N.E., Vargas H., Wheeler C.M. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 2006, 44:1755-1762.
2. Badal S., Badal V., Calleja-Macias I.E., Kalantari M., Chuang L.S.H., Li B.F.L., Bernard H.U. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 2004, 324:483-492.
3. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., de Villiers E.M. Classification of papillomaviruses based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
4. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
5. Brandsma J.L., Sun Y., Lizardi P.M., Tuck D.P., Zelterman D., Haines G.K., Martel M., Harigopal M., Schofield K., Neapolitano M. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009, 389:100-107.
6. Briolat J., Dalstein V., Saunier M., Joseph K., Caudroy S., Pretet J.L., Birembau P., Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int. J. Cancer 2007, 121:2198-2204.
7. Bulkmans N.W., Berkhof J., Rozendaal L., van Kemenade F.J., Boeke A.J., Bulk S., Voorhorst F.J., Verheijen R.H., van Groningen K., Boon M.E., Ruitinga W., van Ballegooijen M., Snijders P.J., Meijer C.J. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation Trial. Lancet 2007, 370:1764-1772.
8. Campitelli M., Jeannot E., Peter M., Lappartient E., Saada S., de la Rochefordiere A., Fourchote V., Alran S., Petrow P., Cottu P., Pierga J.Y., Lantz O., Couturier J., Sastre-Garau X. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLOS ONE 2012, 7:e43393.
9. Clarke M.A., Wentzensen N., Mirabello L., Ghosh A., Wacholder S., Harari A., Lorincz A., Schiffman M., Burk R.D. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol. Biomark. Prev. 2012, 21:2125-2137.
10. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 1997, 78:1095-1101.
11. Doerfler W., Remus R., Muller K., Heller H., Hohlweg U., Schubbert R. The fate of foreign DNA in mammalian cells and organisms. Dev. Biol. 2001, 106:89-97.
12. Feng Q., Balasubramanian A., Hawes S.E., Toure P., Sow P.S., Dem A., Dembele B., Critchlow C.W., Xi L., Lu H., McIntosh M.W., Young A.M., Kiviat N.B. Detection of hypermethylated genes in women with and without cervical neoplasia. J. Natl. Cancer Inst. 2005, 97:273-282.
13. Fernandez A.F., Rosales C., Lopez-Nieva P., Graña O., Ballestar E., Ropero S., Espada J., Melo S.A., Lujambio A., Fraga M.F., Pino I., Javierre B., Carmona F.J., Acquadro F., Steenbergen R.D., Snijders P.J., Meijer C.J., Pineau P., Dejean A., Lloveras B., Capella G., Quer J., Buti M., Esteban J.I., Allende H., Rodriguez-Frias F., Castellsague X., Minarovits J., Ponce J., Capello D., Gaidano G., Cigudosa J.C., Gomez-Lopez G., Pisano D.G., Valencia A., Piris M.A., Bosch F.X., Cahir-McFarland E., Kieff E., Esteller M. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 2009, 19:438-451.
14. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 1992, 89:1827-1831.
15. Häfner N., Driesch C., Gajda M., Jansen L., Kirchmayr R., Runnebaum I.B., Dürst M. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 2008, 27:1610-1617.
16. Hudelist G., Manavi M., Pischinger K.I., Watkins-Riedel T., Singer C.F., Kubista E., Czerwenka K.F. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 2004, 92:873-880.
17. Jeon S., Allen-Hoffmann B.L., Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 1995, 69:2989-2997.
18. Johannsen E., Lambert P.F. Epigenetics of human papillomaviruses. Virology 2013, 445:205-212.
19. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Barrera-Saldana H.A., Wiley D.J., Bernard H.U. Conserved methylation patterns of human papillomavirus-16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 2004, 78:12762-12772.
20. Kalantari M., Lee D., Calleja-Macias I.E., Lambert P., Bernard H.U. Effects of cellular differentiation, chromosomal integration, and 5'-aza-2'-deoxycyticine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 2008, 374:292-303.
21. Kalantari M., Villa L.L., Calleja-Macias I.E., Bernard H.U. Human papillomavirus-16 and 18 in penile carcinomas: DNA methylation, chromosomal recombination, and genomic variation. Int. J. Cancer 2008, 123:1832-1840.
22. Kalantari M., Chase D.M., Tewari K.S., Bernard H.U. Recombination of Human Papillomavirus-16 and Host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. J. Med. Virol. 2010, 82:311-320.
23. Kulmala S.M., Syrjänen S.M., Gyllensten U.B., Shabalova I.P., Petrovichev N., Tosi P., Syrjänen K.J., Johansson B.C. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J. Clin. Pathol. 2006, 59:513-517.
24. Lorincz A.T., Brentnall A.R., Vasiljevic N., Scibior-Bentkowska D., Castanon A., Fiander A., Powell N., Tristram A., Cuzick J., Sasieni P. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. Int. J. Cancer 2013, 133:637-644.
25. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., Ratnam S., Coutlée F., Franco E.L. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 2007, 357:1589-1597.
26. Mirabello L., Schiffman M., Ghosh.A., Rodriguez A.C., Vasiljevic N., Wentzensen N., Herrero R., Hildesheim A., Wacholder S., Scibior-Bentkowska D., Burk R.D., Lorincz A.T. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int. J. Cancer 2012, 1412-1422.
27. Mirabello L., Sun C., Ghosh A., Rodriguez A.C., Schiffman M., Wentzensen N., Hildesheim A., Herrero R., Wacholder S., Lorincz A., Burk R.D. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J. Natl. Cancer Inst. 2012, 104:556-565.
28. Munoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J.F., Meijer C.J.L.M. Epidemiological classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
29. Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., Matchar D.B. Accuracy of the Papaniolaou test in screening for and follow-up of cervical cytologic abnormalities: a sytematic review. Ann. Int. Med. 2000, 132:810-819.
30. Narayan G., Arias-Pulido H., Koul S., Vargas H., Zhang F.F., Villella J., Schneider A., Terry M.B., Mansukhani M., Murty V.V. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of the cervix uteri: Its relationship to clinical outcome. Mol. Cancer 2003, 2:24.
31. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Elfgren K., Rådberg T., Strander B., Johansson B., Forslund O., Hansson B.G., Rylander E., Dillner J. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N. Engl. J. Med. 2007, 357:1589-1597.
32. Pett M., Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?. J. Pathol. 2007, 212:356-367.
33. Stünkel W., Huang Z., Tan S.H., O'Connor M., Bernard H.U. Nuclear matrix attachment regions of human papillomavirus-16 repress or activate the E6 promoter depending on the physical state of the viral DNA. J. Virol. 2000, 74:2489-2501.
34. Stoler M.H., Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. J. Am. Med. Assoc. 2001, 285:1500-1505.
35. Sun C., Reimers L.L., Burk R.D. Methylation of HPV16 genome CpG sites is associated with cervical precancer and cancer. Gynecol. Oncol. 2011, 121:59-63.
36. Tan S.H., Leong L.E.C., Walker P.A., Bernard H.U. The human papillomavirus type 16 transcription factor E2 binds with low cooperativity to two flanking binding sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 1994, 68:6411-6420.
37. Turan T., Kalantari M., Calleja-Macias I.E., Villa L.L., Cubie H.A., Cuschieri K., Skomedal H., Barrera-Saldana H.A., Bernard.H.U. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?. Virology 2006, 349:175-183.
38. Turan T., Kalantari M., Cuschieri K., Cubie H.A., Skomedal H., Bernard H.U. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 2007, 361:185-191.
39. Ueda Y., Enomoto T., Miyatake T., Ozaki K., Yoshizaki T., Kanao H., Ueno Y., Nakashima R., Shroyer K.R., Murata Y. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab. Invest. 2003, 83:1517-1527.
40. Van Tine B.A., Kappes J.C., Banerjee N.S., Knops J., Lai L., Steenbergen R.D., Meijer C.L., Snijders P.J., Chatis P., Broker T.R., Moen P.T., Chow L.T. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J. Virol. 2004, 78:11172-11186.
41. Vinokurova S., Wentzensen N., Kraus I., Klaes R., Driesch C., Melsheimer P., Kisseljov F., Dürst M., Schneider A., von Knebel Doeberitz M. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 2008, 68:307-313.
42. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur. J. Cancer 2002, 38:2229-2242.
43. Wentzensen N., Sherman M.E., Schiffman M., Wang S.S. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol. Oncol. 2009, 112:293-299.
44. Wentzensen N., Sun C., Ghosh A., Kinney W., Mirabello L., Wacholder S., Shaber R., Lamere B., Clarke M., Lorincz A.T., Castle P.E., Schiffman M., Burk R.D. Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3. J. Natl. Cancer Inst. 2012, 104:1738-1749.
45. Xu B., Chotewutmontri S., Wolf S., Clos U., Schmitz M., Dürst M., Schwarz E. Multiplex identification of human papillomavirus 16 DNA integration sites in cervical carcinomas. PLOS ONE 2013, 8:e66693.